Q32 Bio Inc. (QTTB) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Q32 Bio Inc. (QTTB)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.08

-0.02 (-0.65%)

At close: Jan 14, 2025, 3:59 PM

3.06

-0.65%

Pre-market Jan 15, 2025, 04:21 AM EST

undefined% (undefined)

Bid	3.07
Market Cap	37.52M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-4.5
PE Ratio (ttm)	-0.68
Forward PE	n/a
Analyst	Hold

Ask	3.35
Volume	172,445
Avg. Volume (20D)	352,650
Open	3.12
Previous Close	3.10
Day's Range	3.02 - 3.20
52-Week Range	2.99 - 53.79
Beta	undefined

About QTTB

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular ...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Mar 28, 2018

Employees 42

Stock Exchange NASDAQ

Ticker Symbol QTTB

Analyst Forecast

According to 7 analyst ratings, the average rating for QTTB stock is "Hold." The 12-month stock price forecast is $20, which is an increase of 549.35% from the latest price.

Buy 42.86%

Hold 57.14%

Sell 0.00%

Stock Forecasts

Why Price Moved

1 month ago · Source

-28.57%

Q32 Bio shares are trading lower after Guggenheim ... Unlock content with Pro Subscription

1 month ago · Source

-75.62%

Q32 Bio shares are trading lower after multiple firms downgraded the stock and cut their respective price targets on the stock.

News

1 week ago · zacks.com

Q32 Bio (QTTB) Upgraded to Buy: What Does It Mean for the Stock?

Q32 Bio (QTTB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago · zacks.com

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

Shares of QTTB fall after its experimental autoimmune disease drug failed to meet the primary endpoint in a mid-stage study for eczema.

1 month ago · benzinga.com

Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday?

On Wednesday, Q32 Bio Inc. QTTB revealed topline results from the SIGNAL-AA Phase 2a signal finding trial evaluating bempikibart (ADX-914) for alopecia areata (AA).

1 month ago · investors.com

Q32 Bio Crashes 67% On A 'Messy' Update In Eczema, Alopecia Treatment

Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record low. The post Q32 Bio Crashes 67% On A 'Messy' Update In Eczema, Alopecia Tr...